Autism in Aotearoa: Is the RAADS-14 a valid tool for a New Zealand population?

dc.citation.issue3
dc.citation.volume37
dc.contributor.authorKember S
dc.contributor.authorWilliams MN
dc.date.available2021-06
dc.date.issued2020-07-06
dc.descriptionThis version of the article may not completely replicate the final authoritative version published in European Journal of Psychological Assessment at https://doi.org/10.1027/1015-5759/a000598. It is not the version of record and is therefore not suitable for citation. Please do not copy or cite without the permission of the author(s).
dc.description.abstractScreening measures for autism spectrum disorder (ASD) are important tools for clinicians and researchers. However, where a measure developed and validated for one population is used with another, its performance in this new context must be carefully examined. The RAADS-14, a brief ASD screen developed in Sweden, was evaluated with a sample of New Zealand adults (N = 387), 41 of whom self-reported a prior diagnosis of ASD. The convergent validity of the RAADS-14 (Hypothesis 2) was supported by a strong positive correlation with the AQ-10 (short version of the Autism Spectrum Quotient), r = .81. Discriminant validity (Hypothesis 3) was also supported by a strong negative correlation with the EQ-Short (short version of the Empathy Quotient), r = −.75. However, the measure did not meet inferential criteria for internal consistency (Hypothesis 1), and confirmatory factor analysis (CFA) found a poor fit of the proposed three-factor model (Hypothesis 4) to the data. A cut-off score of 14/42 provided adequate sensitivity (95%) to detect participants with self-reported ASD diagnoses, but not adequate specificity (70%), suggesting a very high rate of false positives should be expected if relying on RAADS-14 scores alone to interpret presence of ASD. In sum, our results do not provide sufficient evidence of reliability and validity to support the use of the RAADS-14 with the New Zealand population. We provide suggestions for refinement of the RAADS-14 that may lead to increased reliability and validity.
dc.description.publication-statusPublished
dc.format.extent247 - 257
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000755115200009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=c5bb3b2499afac691c2e3c1a83ef6fef
dc.identifier.citationEUROPEAN JOURNAL OF PSYCHOLOGICAL ASSESSMENT, 2021, 37 (3), pp. 247 - 257
dc.identifier.doi10.1027/1015-5759/a000598
dc.identifier.eissn2151-2426
dc.identifier.elements-id433227
dc.identifier.harvestedMassey_Dark
dc.identifier.issn1015-5759
dc.publisherHogrefe for the European Association of Psychological Assessment (EAPA)
dc.relation.isPartOfEUROPEAN JOURNAL OF PSYCHOLOGICAL ASSESSMENT
dc.subjectautism spectrum disorder
dc.subjectASD
dc.subjectRAADS-14
dc.subjectscreening
dc.subjectvalidity
dc.subject.anzsrc1701 Psychology
dc.titleAutism in Aotearoa: Is the RAADS-14 a valid tool for a New Zealand population?
dc.typeJournal article
pubs.notesNot known
pubs.organisational-group/Massey University
pubs.organisational-group/Massey University/College of Humanities and Social Sciences
pubs.organisational-group/Massey University/College of Humanities and Social Sciences/School of Psychology
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kember Williams 2020 accepted manuscript.pdf
Size:
466.06 KB
Format:
Adobe Portable Document Format
Description:
Collections